Published by Oxford University Press 2007.
Dysfunctional and Compensatory Prefrontal Cortical Systems, Genes and the Pathogenesis of Schizophrenia
Genes, Cognition and Psychosis Program, Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA
Address correspondence to Daniel R. Weinberger, MD, Director of Genes, Cognition and Psychosis Program, IRP, NIMH, NIH, Rm. 4S-235, 10 Center Drive, Bethesda, MD 20892, USA. Email: daniel.weinberger{at}mail.nih.gov.
| Abstract |
|---|
|
|
|---|
Cognitive deficits are critical determinants of schizophrenia morbidity. In this review, we offer a mechanistic perspective regarding schizophrenia-related changes observed in prefrontal cortical networks engaged in working memory. A body of earlier work converges on aberrations in putative macrocircuit stability and functional efficiency as the underlying pathophysiology of the cognitive deficits in schizophrenia. In parsing the dysfunctional prefrontal cortical dynamics of schizophrenia, recent functional magnetic resonance imaging and electoencephalography works suggest that in the context of reduced capacity for executive aspects of working memory, patients engage a larger network of cortical regions consistent with an interplay between reduced signal-to-noise components and the recruitment of compensatory networks. The genetic programming underlying these systems-level cortical interactions has been examined under the lens of certain schizophrenia susceptibility genes, especially catechol-o-methyltransferase (COMT) and GRM3. Variation in COMT, which presumably impacts on cortical dopamine signaling, translates into variable neural strategies for working memory and altering patterns of intracortical functional correlations. GRM3, which impacts on synaptic glutamate, interacts with COMT and exaggerates the genetic dissection of cortical processing strategies. These findings reveal novel insights into the modulation and parcellation of working memory processing in cortical assemblies and provide a mechanistic link between susceptibility genes and cortical pathophysiology related to schizophrenia.
Key Words: dopamine fMRI genetics glutamate psychosis working memory
| Introduction |
|---|
|
|
|---|
Understanding the neurobiology of schizophrenia remains a significant challenge of public health importance. Cognitive dysfunction is a core feature of schizophrenia, and a key focus of investigation given its impact on functional outcome and chronic disease morbidity, largely unaffected by the present pharmacopoeia (Goldberg and Weinberger 1996
| Prefrontal Cortex, Working Memory, and Schizophrenia |
|---|
|
|
|---|
The prefrontal cortex is involved in working memory and related higher-cognitive processes like planning and goal-directed activity (Goldman-Rakic 1995
There is abundant evidence that the prefrontal cortex and working memory are abnormal in schizophrenia. Postmortem studies have shown increased neuronal density in the dorsolateral prefrontal cortex of patients with schizophrenia (Garey et al. 1998
; Harrison 1999
; Selemon and Goldman-Rakic 1999
; Glantz and Lewis 2000
). Cognitive deficits, including working memory, may occur before the onset of psychosis (Jones et al. 1994
; Davidson et al. 1999
; Cannon et al. 2002
; Fuller et al. 2002
; Ang and Tan 2004
), and are certainly present by the first-episode and thereafter (Goldberg and Weinberger 1988
; Park and Holzman 1992
; Keefe et al. 1995
; Gold et al. 1997
; Bilder et al. 2000
; Weickert et al. 2000
). An extensive body of functional imaging experiments is consistent with prefrontal cortical physiological dysfunction in schizophrenia (Weinberger et al. 1986
; Andreasen et al. 1992
; Fletcher et al. 1998
; Manoach et al. 1999
, 2000
; Callicott et al. 2000
; Barch et al. 2001
; Meyer-Lindenberg et al. 2001
; Perlstein et al. 2001
; Callicott, Mattay, et al. 2003
; Manoach 2003
; Schlosser, Gesierich, Kaufmann, Vucurevic, Hunsche, et al. 2003
; Schlosser, Gesierich, Kaufmann, Vucurevic, Stoeter 2003
; Tan et al. 2005
, 2006
). This is characterized by abnormal activation relative to healthy controls. As we will elaborate, emerging studies argue that the directionality of the findings (i.e., too much or too little prefrontal activity) depend on the specific task paradigm utilized, disease-related differences in behavioral performance, and capacity constraints of task load (Callicott et al. 1999
, 2000
; Ramsey et al. 2002
; Callicott, Mattay, et al. 2003
; Manoach 2003
), and possibly the engagement of dysfunctional and compensatory macrocircuits (Tan et al. 2005
, 2006
). Contemporary functional neuroimaging therefore affords the opportunity to further elaborate the dynamics of these complex pathophysiological processes underlying what appears to be inefficient brain function in schizophrenia.
| Dysfunctional Prefrontal Cortical Dynamics in Schizophrenia |
|---|
|
|
|---|
Early functional imaging studies in schizophrenia have documented reduced frontal-lobe regional cerebral blood flow at rest and during complex tasks involving executive function (for review, see Callicott and Weinberger 1999
A concern has often been raised regarding the impact of patients' poorer performance on cortical activation differences per se, as well as how this might reflect differences in the capacity limitation of working memory between patients and controls. Capacity limitation, a key feature of working memory, is usually reflected in cognitive testing as decreasing performance in response to increasing working memory load (Shallice 1988
; Just and Carpenter 1996
; Fuster 1997
). In addressing the dynamic range of physiological responses that presumably underlie variations in capacity during an N-back working memory task with increasing cognitive load, it was found that regions within the healthy dorsolateral prefrontal cortex evinced a nonlinear "inverted-U" shaped physiological response (Callicott et al. 1999
; Mattay et al. 2003
; Jansma et al. 2004
). Thus, areas of prefrontal cortical activation increased with task load and difficulty, alongside decreased accuracy and slower reaction time. This occurred to an extent defined by the individual's working memory capacity, after which continued increase in task load resulted in decreased prefrontal cortical activation. This is analogous to findings with single-unit recordings in monkeys (Goldman-Rakic 1990
) and with EEG evoked potentials in humans (Gevins et al. 1997
), that is, that memory error is associated with failure of engagement of the appropriate cortical response network. It has been suggested that the working memory capacity of schizophrenia patients is relatively reduced to account for their deficits in cognitive performance and their tendency to disengage prefrontal cortical activation when their performance is failing (Fletcher et al. 1998
; Callicott, Mattay, et al. 2003
; Jansma et al. 2004
). Patients therefore seem to fall off the information processing "treadmill" at a lower cognitive load, possibly as a reflection of underlying neuronal pathology (Weinberger et al. 2001
).
These considerations, however, still leave unresolved the possibility that nonspecific factors like psychological disengagement or lack of effort could confound the finding of reduced working memory capacity and prefrontal activation in patients (Weinberger and Berman 1996
). A complementary approach, therefore, has been to study patients whose working memory performance is at or near normal, or to account for performance deficits by analyzing only correct trials within an event-related study design. This approach often yielded the intriguing finding of regions with intact or relatively increased prefrontal cortical activation (Curtis et al. 1999
; Manoach et al. 1999
, 2000
; Callicott et al. 2000
; Ramsey et al. 2002
; Callicott, Mattay, et al. 2003
; Manoach 2003
; MacDonald et al. 2005
; Tan et al. 2005
, 2006
), which cannot easily be interpreted as reflecting nonspecific disengagement, lack of effort, or poor performance. Instead, the results of these studies suggest that when patients are able to keep up with the processing demands, they tend to do so less efficiently by engaging greater cerebral metabolic activity or a less focused cortical activity state. This might be analogous to the recruitment of extraneous neural activity in the early phases of a variety of learning paradigms, when the optimal cognitive strategy has not been arrived at, and when the task might conceivably be found to be more difficult (Andreasen et al. 1995
; Shadmehr and Holcomb 1997
; Petersen et al. 1998
; Rypma and D'Esposito 1999
; Ramsey et al. 2004
). It might also parallel the reorganization in neural strategy following cortical injury with the redistribution of increased activity to functionally related healthy brain regions (Johansen-Berg et al. 2002
). Indeed, if performance is preserved, then at least part of the increased or intact activation might serve to compensate for some underlying neural dysfunction, even as the overall network architecture might be inefficient. EEG evoked potential studies have suggested that this loss of an efficient or tuned response may represent a decrease in signal to noise or a failure of response stability within the cortical microcircuits that support these cognitive operations (Winterer, Egan, et al. 2006
). This concept has recently been extended in an fMRI study of simple choice reaction time in patients with schizophrenia, in which signal to noise and independent component analyses revealed greater noise and more independent components within medial prefrontal cortex during the establishment of even this simple response (Winterer, Musso, et al. 2006
).
| Dysfunctional and Compensatory Cortical Networks in Schizophrenia |
|---|
|
|
|---|
The conceptualization that there might be an interplay of dysfunctional and compensatory cortical regions or networks in schizophrenia gains traction in view of recent trends to examine specific working memory subprocesses that engage combinations of prefrontal subregions and associated nodes in the extended working memory network. As alluded to by previous behavioral (Goldberg et al. 1998
Conversely, schizophrenia patients with near normal working memory performance sometimes have shown activation patterns in the ventrolateral prefrontal cortex that were either intact (Barch et al. 2001
; Perlstein et al. 2001
; Kim et al. 2003
; Meyer-Lindenberg, Olsen, et al. 2005
), or increased (Callicott, Mattay, et al. 2003
; Glahn et al. 2005
; MacDonald et al. 2005
; Tan et al. 2005
, 2006
), possibly in compensation for the dysfunctional dorsolateral prefrontal response. A series of recent fMRI findings examining brain–behavior correlations and frontoparietal functional connectivity support this interpretation (Tan et al. 2006
): working memory performance was correlated with dorsolateral prefrontal cortical activation in healthy controls, but this relationship occurred at the ventrolateral prefrontal cortex in patients; and although healthy controls had relatively greater frontoparietal functional connectivity with the dorsolateral prefrontal cortex, schizophrenia patients evinced increased ventrolateral frontoparietal functional connectivity that was reciprocally related to deficits in the dorsal regions (Fig. 1). Thus, although healthy controls optimally utilized the dorsolateral prefrontal cortex in executive working memory tasks, schizophrenia patients were unable to do so but engaged greater ventrolateral prefrontal cortex involvement instead. Furthermore, poorer performing patients activated another region in the ventrolateral prefrontal cortex more than better performing patients, suggesting that this compensatory strategy might not always result in improved performance (Tan et al. 2006
). The compensatory response may thus reflect a relative loss of hierarchical functional specialization in the diseased prefrontal cortex, where optimum dorsolateral prefrontal function is compromised and accompanied by a greater reliance on less efficient ventrolateral prefrontal engagement. Although resulting in a limited restoration of performance through a reweighting of the distributed neuronal architecture, the overall neural circuitry is likely to be unstable, may have a more limited functional capacity, and may eventually fail to maintain cognitive performance (i.e., reach capacity at lower levels of cognitive complexity). Still, how might these systems-level prefrontal cortical interactions relate to the core biology of schizophrenia in terms of key neurotransmitter complexes and the genes that program the wiring of this circuitry?
|
| Imaging Genetics of Working Memory and Risk for Schizophrenia |
|---|
|
|
|---|
DA-ergic and glutamatergic abnormalities have long served as major theoretical frameworks for understanding the pathophysiology as well as pharmacology of schizophrenia and its cognitive deficits, particularly working memory (Weinberger et al. 1988
These molecular and single-neuron paradigms resonate with suggestions that the functional architecture of the lateral prefrontal cortex could be hierarchically organized, whereby the more anterior and dorsal regions are thought to be engaged in higher-order executive processing (D'Esposito et al. 1999
; Koechlin et al. 2003
), wherein manipulation of information in memory has recently been modeled in integrate-and-fire networks to engage more inhibitory processing (Deco et al. 2004
; Deco and Rolls 2005
). Thus, it would be conceivable that changes in signal-to-noise processing through the DA-ergic D1-receptor or related NMDA or GABA receptor systems in the prefrontal cortex would tend to enhance or to degrade working memory predictably along the inverted-U shaped tuning curve (Williams and Goldman-Rakic 1995
; Seamans and Yang 2004
), and that executive aspects of working memory would be more sensitive to these variable effects.
Indeed, extensions of these hypotheses to the more complex in vivo human cortex have, in recent years, supported these possibilities (Egan, Goldberg, Kolachana, et al. 2001
; Weinberger et al. 2001
; Mattay et al. 2003
; Egan et al. 2004
; Bertolino et al. 2004
; Blasi et al. 2005
; Meyer-Lindenberg, Kohn, et al. 2005
). This has been facilitated by examining the effects of an increasing set of putative schizophrenia candidate genes (particularly COMT and GRM3) using neuroimaging of working memory. Although these genes by themselves have modest effects on schizophrenia risk per se (Harrison and Weinberger 2005
), their influence on key DA-ergic and glutamatergic neurotransmitter signaling pathways implicated in more constrained intermediate phenotypes such as working memory provides a powerful approach to examine the relationships between the biology of schizophrenia risk and specific brain function in vivo (Meyer-Lindenberg and Weinberger 2006
).
The study of catechol-o-methyltransferase (COMT) is an important example of recent studies linking genes to cortical physiologic organization. COMT is a major enzyme in synaptic DA catabolism with a critical role in prefrontal cortical DA signaling because of the relative lack of DA transporters in this region (Seasack et al. 1998
; Lewis et al. 2001
; Chen et al. 2004
). A common polymorphism in the COMT gene resulting from a valine-to-methionine Val(108/158)Met substitution gives rise to a significant reduction in its enzymatic activity in the prefrontal cortex and in peripheral tissues (Lotta et al. 1995
; Lachman et al. 1996
; Chen et al. 2004
). This is thought to correspond to reduced prefrontal DA in proportion to Val-allele load—the allele that has been weakly associated with risk for schizophrenia and psychosis. Located on chromosome 22q11, this susceptibility locus has been implicated in meta-analyses of linkage to schizophrenia (Badner and Gershon 2002
; Lewis et al. 2003
). COMT is also deleted in velocardiofacial syndrome, a condition that has a 20 times increased risk for schizophrenia (Murphy 2002
). However, the effect on risk for schizophrenia of the specific COMT Val(108/158)Met polymorphism is small and inconsistent (Glatt et al. 2003
; Fan et al. 2005
). This is not surprising given the manifold factors associated with schizophrenia pathogenesis, such as the interaction of genes and environmental conditions (Caspi et al. 2005
).
In contrast, investigations of the effect of the COMT Val(108/158)Met polymorphism on working memory have converged with that predicted by cellular models of prefrontal DA previously described. Reduced prefrontal DA in COMT Val-carriers, presumably through decreased tonic D1-receptor activation, would be expected to result in firstly, reduced cortical signal-to-noise; secondly, a relatively inefficient and detuned prefrontal cortical activation map if performance accuracy is still maintained; and ultimately, reduced working memory and executive function. Each of these predictions have been borne out, and COMT genotypes were found to account for about 3–4% of the variance in performance on frontal-lobe tests, with poorer performance in subjects carrying the Val- rather than the Met-allele, even in normal subjects (Egan, Goldberg, Kolachana, et al. 2001
; Malhotra et al. 2002
; Goldberg et al. 2003
; Nolan et al. 2004
; de Frias et al. 2006
). Analogous results were obtained in normal children (Diamond et al. 2004
). Correspondingly, using fMRI to study cortical activity, healthy Val-allele carriers engaged relatively greater N-back prefrontal cortical activation, consistent with the conclusion that Val carriers are relatively less efficient (Egan, Goldberg, Kolachana, et al. 2001
; Mattay et al. 2003
; Meyer-Lindenberg et al. 2006
). As might be predicted by the greater dependence on dorsolateral prefrontal cortical processing of higher-executive tasks (D'Esposito et al. 1999
; Koechlin et al. 2003
; Deco et al. 2004
; Deco and Rolls 2005
), these COMT effects in dorsolateral prefrontal cortex were more prominent at higher working memory loads (Mattay et al. 2003
). The study by Mattay et al. (2003)
also showed that the putatively inefficient prefrontal cortical activation in Val-homozygotes could be improved by the dopamimetic amphetamine, resulting in a more focused reduction of dorsolateral prefrontal activation as it became more optimally modulated, or closer to its peak on the inverted-U prefrontal DA tuning curve (Mattay et al. 2003
). Conversely, Met-homozygotes, who were presumably already at the peak at baseline, appeared to be pushed off the peak of the curve by amphetamine, resulting in the adoption of a relatively inefficient (increased) cortical activation pattern (Fig. 2). Using an EEG evoked potential analysis based on signal-to-noise during the P300 oddball paradigm, it was recently demonstrated that COMT Val-allele load was associated with poorer signal-to-noise during this paradigm in prefrontal cortex, in patients with schizophrenia, in their healthy siblings, and also in normal subjects (Winterer, Egan, et al. 2006
). These studies strongly indicate that this functional polymorphism in COMT impacts on the stability and tuning of cortical circuitry during working memory processing.
|
Cortical information processing, especially in prefrontal cortex, impacts on the regulation of DA activity in the mesencephalon (Winterer and Weinberger 2004
Like DA, glutamatergic abnormalities are important in schizophrenia and working memory function, and it follows that disease-related mutations in glutamate signaling could similarly impair its function. This has been found to be the case for GRM3 (Egan et al. 2004
), a heteroceptor modulating NMDA-receptor transmission, and located on chromosome 7q21–22 (Moghaddam and Adams 1998
; Egan et al. 2004
; Harrison and Weinberger 2005
). A polymorphism in intron 2 and related haplotypes were significantly associated with schizophrenia in several samples (Martí et al. 2002
; Egan et al. 2004
; Fallin et al. 2005
; Chen et al. 2005
), though negative studies also have been reported (Norton et al. 2005
). GRM3 regulates synaptic glutamate via a presynaptic mechanism and by regulating the expression of the glial glutamate transporter, which inactivates synaptic glutamate. Risk variants in GRM3 may be a factor influencing alternative splicing of the GRM3-receptor (Sartorius et al. 2006
). In postmortem brain, the risk allele is associated with reduced prefrontal glial glutamate transporter EAAT2, a protein modulating synaptic glutamate (Egan et al. 2004
). Consistent with the role of the glutamatergic system in schizophrenia and working memory, the risk allele was associated with inefficient prefrontal cortical fMRI activation and reduced working memory performance even in normal subjects (Egan et al. 2004
).
Critically, given the tight relationships governing DA-ergic, and glutamatergic (and GABAergic) dynamics in the biology of working memory (Sawaguchi and Goldman-Rakic 1991
; Williams and Goldman-Rakic 1995
; Lisman et al. 1998
; Wang 1999
; Durstewitz and Seamans 2002
; Seamans and Yang 2004
), and their putatively greater involvement in executive aspects of working memory at the dorsolateral prefrontal cortex (D'Esposito et al. 1999; Koechlin et al. 2003
; Mattay et al. 2003
; Deco et al. 2004
; Deco and Rolls 2005
), we would expect that higher-order working memory processes taxing dorsolateral prefrontal cortex might be more vulnerable to the combined effect of suboptimal DA-ergic and glutamatergic influence. If these processes were related to the prefrontal deficits associated with schizophrenia, a similar pattern of inefficiently increased dorsolateral prefrontal cortical activation might occur in the context of relatively preserved cognitive performance (Curtis et al. 1999
; Manoach et al. 1999
, 2000
; Callicott et al. 2000
; Ramsey et al. 2002
; Callicott, Mattay, et al. 2003
; Manoach 2003
; Tan et al. 2005
, 2006
). Moreover, this pattern of relatively increased activation predicted during suboptimal DA-ergic and glutamatergic function might also be associated with reduced frontoparietal functional connectivity as found in schizophrenia (Tan et al. 2006
). Correspondingly, putative compensatory activation from the ventrolateral prefrontal cortical regions (Barch et al. 2001
; Perlstein et al. 2001
; Callicott, Mattay, et al. 2003
; Kim et al. 2003
; Glahn et al. 2005
; MacDonald et al. 2005
; Meyer-Lindenberg, Olsen, et al. 2005
; Tan et al. 2005
, 2006
) would be engaged with reciprocal increased activation and frontoparietal functional connectivity. Consistent with the interplay of cortical macrocircuits suggested by these possibilities, a recent fMRI study revealed that the integrity of higher-executive areas in the dorsolateral prefrontal cortex could be disproportionately compromised and inefficient in the presence of combined deleterious COMT and GRM3 genotypes in normal subjects, with a reweighting of activity to the ventrolateral prefrontal cortex if performance was maintained (Fig. 3) (Tan et al., 2007).
|
If confirmed, these findings could extend putative brain DA-ergic and glutamatergic cross-talk to the level of in-vivo neural systems interactions in cortical circuits implicated in working memory dysfunction and in schizophrenia. To the extent that these complex genetic associations mimic biological phenomena related to schizophrenia, they suggest that the neurobiology of schizophrenia involves dynamic changes to cortical systems as they adapt to these adverse neurobiological environments through the additional engagement of related cortical networks—possibly those usually engaged by processes lower in the cognitive processing hierarchy such as the ventrolateral prefrontal cortex. This example of putative disease-related functional plasticity appears at least in part genetically driven, and dissociable. The disproportionately inefficient prefrontal response associated with the combined deleterious genotypes of COMT and GRM3 also underlies an important concept in complex genetic diseases—that of epistatic interactions between genes, each of small individual effect. Thus, COMT, GRM3, and/or closely related downstream molecular events could play leading roles in human working memory and the pathogenesis of schizophrenia and could provide a foothold for other clinically relevant investigations.
| Future Directions |
|---|
|
|
|---|
Future work will need to elaborate on these early leads in several major areas—particularly in elaborating the related molecular events, and the developmental pathophysiology of schizophrenia. It would be critical to improve upon the resolution of how genetic variation (and indeed haplotypic variation; The International HapMap Consortium 2005
Another major avenue of future work is to consider these networks in terms of their neurodevelopmental phases. Core cognitive deficits, in which working memory plays a leading role, are likely to have begun before the first psychotic episode (Jones et al. 1994
; Davidson et al. 1999
; Cannon et al. 2002
; Fuller et al. 2002
; Ang and Tan 2004
). Healthy siblings of schizophrenia patients have working memory deficits (Egan, Goldberg, Gscheidle, et al. 2001
), as well as prefrontal cortical activation abnormalities (Callicott, Egan, et al. 2003
). The prefrontal cortex is one of the last structures to mature in humans, and key changes occur in prefrontal cortical neurons around adolescence, particularly in terms of the enhanced inhibition critical for executive function (Lewis et al. 2004
). These developmental changes might therefore be both temporally and causally related to the onset of prodromal symptoms and the first psychotic episode, which tend to occur at late adolescence and early adulthood (Weinberger 1987
; McGlashan and Hoffman 2000
; Lewis et al. 2004
). However, relatively little is understood about how the functional architecture of working memory, genes, and brain developmental trajectories interact, and how this might lead to a decompensation in those destined to develop psychosis, although some data on language deficits are emerging from longitudinal studies of high-risk subjects (Whalley et al. 2004
, 2006
). It might be conceivable that subtle cortical network physiological differences exist vis-à-vis recent findings of cortical thickness changes during longitudinal neurodevelopmental studies in schizophrenia, velocardiofacial syndrome, Williams syndrome, and attention-deficit-hyperactivity disorder (Thompson et al. 2001
; Toga et al. 2006
).
Finally, understanding how schizophrenia susceptibility alleles influence working memory in the brain could provide clues about biomarkers and targets for novel treatment and preventative strategies. The COMT genotype was recently demonstrated to influence improvement in working memory following antipsychotic treatment. Individuals homozygous for the COMT Met-allele improved more in working memory after antipsychotic treatment (Bertolino et al. 2004
; Weickert et al. 2004
). Notably, this was reflected by a more efficient dorsolateral prefrontal cortical function following treatment (Bertolino et al. 2004
). Better understanding of how COMT and other factors associated with disease neurodevelopment and medication response intersect as a function of brain DA could serve as a starting point in identifying novel treatment targets. Indeed, a study of tolcapone, a central nervous system penetrant COMT inhibitor, has found a salutary effect of this drug on working memory performance in healthy volunteer subjects, especially in COMT Val-allele carriers, and also an improvement in prefrontal cortical efficiency measured with fMRI (Apud et al. 2007
). The results of tolcapone in patients with schizophrenia are eagerly anticipated. The emerging data also suggest that dynamic changes in cortical systems occur as they adapt to adverse neurobiological conditions, perhaps through the engagement of additional cortical networks, and resulting in an overall less efficient neural architecture that is ultimately dysfunctional (Callicott, Mattay, et al. 2003
; Corbetta et al. 2005
; Tan et al. 2005
, 2006
, unpublished manuscript). Further evaluation of the effects of treatments on these processes should be warranted through the study of disease susceptibility genes, in combination with longitudinal follow-up, advances in experimental task design, and the use of multimodal neuroimaging. There are potentially powerful synergies in linking fMRI with the temporal resolution of megnetoencephalography or EEG (Horwitz and Poeppel 2002
) and the enhanced structural connectivity measurements of diffusion-tensor imaging (Kim DS and Kim M 2005
). These developments will herald an era of rapid bidirectional dataflow between cellular molecular models, and the in-vivo human brain in health and disease, leading perhaps toward cures and prevention (Insel and Scolnick 2006
).
| Acknowledgments |
|---|
This work was supported by the US National Institute of Mental Health Intramural Research Program, and a National Institutes of Health Visiting Fellowship (to H.Y.T.). Conflict of Interest: None declared.
| References |
|---|
|
|
|---|
Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci (2003) 23:2008–2013.
Andreasen NC, O'Leary DS, Arndt S, Cizadlo T, Rezai K, Watkins GL, Boles Ponto LL, Hichwa RD. I. PET studies of memory: novel and practiced free recall of complex narratives. NeuroImage (1995) 2:284.[CrossRef][ISI][Medline]
Andreasen NC, Rezai K, Alliger R, Swayze Ii VW, Flaum M, Kirchner P, Cohen G, O'Leary DS. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry (1992) 49:943.[ISI][Medline]
Ang YG, Tan HY. Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry Res (2004) 121:303–307.[CrossRef][ISI][Medline]
Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, et al. Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology (2007) 32:1011–1020.[CrossRef][ISI][Medline]
Awh E, Jonides J, Smith EE, Schumacher EH, Koeppe RA, Katz S. Dissociation of storage and rehearsal in verbal working memory: evidence from positron emission tomography. Psychol Sci (1996) 7:25–31.[CrossRef][ISI]
Baddeley AD. Working memory: looking back and looking forward. Nat Rev Neurosci (2003) 4:829–839.[CrossRef][ISI][Medline]
Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry (2002) 7:405–411.[CrossRef][ISI][Medline]
Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, Noll DC, Cohen JD. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry (2001) 58:280–288.
Barch DM, Csernansky JG, Conturo T, Snyder AZ. Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? J Abnorm Psychol (2002) 111:478–494.[CrossRef][ISI][Medline]
Barch DM, Sheline YI, Csernansky JG, Snyder AZ. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry (2003) 53:376.[CrossRef][ISI][Medline]
Berman KF, Doran AR, Pickar D, Weinberger DR. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry (1993) 162:183–192.
Bertolino A, Caforio G, Blasi G, Candia MD, Latorre V, Petruzzella V, Altamura M, Nappi G, Papa S, Callicott JH, et al. Interaction of COMT Val108/158 met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry (2004) 161:1798–1805.
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JMJ, Woerner MG, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry (2000) 157:549–559.
Blasi G, Mattay VS, Alessandro B, Elvevåg B, Callicott JH, Das S, Kolachana B, Egan MF, Goldberg TE, Weinberger DR. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci (2005) 25:5038–5045.
Braver TS, Barch DM, Cohen JD. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry (1999) 46:312.[CrossRef][ISI][Medline]
Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 10:1078–1092.
Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry (2003) 160:709–719.
Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 9:20–26.
Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry (2003) 160:2209–2215.
Callicott JH, Tallent K, Bertolino A, Knable MB, Coppola R, Goldberg T, Mattay VS, Weinberger DR, Van Gelderen P, Moonen CTW, et al. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology. (1998) 18:186.[CrossRef][ISI][Medline]
Callicott JH, Weinberger DR. Neuropsychiatric dynamics: the study of mental illness using functional magnetic resonance imaging. Eur J Radiol (1999) 30:95.[CrossRef][ISI][Medline]
Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, Poulton R. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder—results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 59:449–456.
Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. Interactions between monoamines, glutamate, and GABA in schizophrenia: new Evidence. Annu Rev Pharmacol Toxicol (2001) 41:237–260.[CrossRef][ISI][Medline]
Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry (1998) 155:1285–1287.
Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry (2005) 57:1117–1127.[CrossRef][ISI][Medline]
Cavada C, Goldman-Rakic PS. Posterior parietal cortex in rhesus monkey: II. Evidence for segregated corticocortical networks linking sensory and limbic areas with the frontal lobe. J Comp Neurol (1989) 287:422–445.[CrossRef][ISI][Medline]
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet (2004) 75:807–821.[CrossRef][ISI][Medline]
Chen Q, He G, Chen Q, Wu S, Xu Y, Feng G, Li Y, Wang L, He L. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res (2005) 73:21.[CrossRef][ISI][Medline]
Corbetta M, Kincade MJ, Lewis C, Snyder AZ, Sapir A. Neural basis and recovery of spatial attention deficits in spatial neglect. Nat Neurosci (2005) 8:1603.[CrossRef][ISI][Medline]
Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci (2003) 1003:318–327.[CrossRef][ISI][Medline]
Curtis VA, Bullmore ET, Morris RG, Brammer MJ, Williams SCR, Simmons A, Sharma T, Murray RM, McGuire PK. Attenuated frontal activation in schizophrenia may be task dependent. Schizophr Res (1999) 37:35–44.


